Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-2276

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-2276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

OXcarbazepine is a pharmaceutical drug packaged in 30 HD2 quantities and is only available through a prescription. The product's NDC number is 70518-2276-00, the manufacturing company is Breckenridge, located in Boca Raton, FL 33487. The Lot number and expiration date are missing. The drug should be kept at a temperature of 20-26°C (63-77°F), with excursions allowed up to 15-30°C (59-86°F), as indicated by USP guidelines. The package insert should always be consulted before use. The product was repackaged by RemedyRepack Inc., an Indiana-based company.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This is a graph showing the exit rate and the log-rank test p-value. The graph has a horizontal and a vertical axis with the time duration in days. There are two curves represented, but the only labeled curve is for Placebo. The graph has a spike in the exit rate at day 2, which returns to baseline by day 11. The value of p is 0.0001, which is statistically significant.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This is a statistical report on the seizure rate of two treatment groups. The log-rank test shows a p-value of 0.046, indicating there is a statistically significant difference between the two groups. The graph displays the number of days from the first dose of medication to the first seizure for each group. One group was treated with Oxcarbazepine, while the other received a placebo.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

The text describes the result of a statistical analysis using a log-rank test, which resulted in a p-value of 0.0001. It also includes a graph with two treatment groups (HIGH and LOW) and their respective time to exit in days. Therefore, the text is a useful description of an experiment comparing exit rates between two treatment groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.